NPI registry status
Active
2026 NPPES data Pain Medicine (Psychiatry & Neurology) Physician NPI 1316105182 M.D.
Verify on CMS → Troy Beaucoudray, M.D.
Pain Medicine (Psychiatry & Neurology) Physician in Metairie, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 169 in Pain Medicine (Psychiatry & Neurology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
14K
Medicare Part D claims · 626 beneficiaries · Pain Medicine (Psychiatry & Neurology) Physician avg: 2K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
17.5/100
▼ 66 pts below national avg 83.5 · Penalty band
Industry payments
$1.1K
67 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Troy Beaucoudray, M.D. reported a CMS MIPS final score of 17.5/100 - below the 83.5 national average - and filed 13,605 Medicare Part D claims in 2024.
- 17.5/100
- MIPS score · -66 vs avg
- 14K
- Part D claims, 2024
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Troy Beaucoudray, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1316105182), first enumerated 05/29/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 13,605 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 17.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$1.1K in reported industry payments (67 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1316105182 · Pain Medicine (Psychiatry & Neurology) Physician
NPI-10 · ENUM-MID · TAX-TRACE · MIPS-LOW · RX-HEAVY · BOOK-THIN · NEAR-MIPS
- NPI-10 1316105182
- ENUM-MID 2008
- TAX-TRACE 169
- MIPS-LOW 17.5/100
- RX-HEAVY 14K claims
- BOOK-THIN 3 in Louisiana
- NEAR-MIPS Sarah Blake · 17.5
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Sarah Blake · lo… 0
Sarah Blake
0 MIPS pts
- Robert Hansen · … 0
Robert Hansen
0 MIPS pts
- Nader Sawiris · … 0
Nader Sawiris
0 MIPS pts
- Beaucoudray · th… 17.5
Beaucoudray · this provider
17.5 MIPS pts
- Julian Motzkin ·…
Julian Motzkin
74.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Troy Beaucoudray, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
18 ≥ 2nd percentile 2% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Troy Beaucoudray, M.D. sits
This provider among pain medicine (psychiatry & neurology) physician peers
Across the 32 pain medicine (psychiatry & neurology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Troy Beaucoudray, M.D. writes more Part D claims than 97% of them and scores higher on MIPS quality than 9% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pain medicine (psychiatry & neurology) physician peer from a representative sample of 31; the gold marker is Troy Beaucoudray, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Troy Beaucoudray, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Troy Beaucoudray, M.D.?
Below national averagePrimary specialty
Pain Medicine (Psychiatry & Neurology) Physician
Medicare Part D claims
13,605 8× vs specialty avg
MIPS final score
17.5/100 66 pts vs avg
Specialty distribution in Louisiana
How Pain Medicine (Psychiatry & Neurology) Physician compares to other specialties among Louisiana providers
Medicare quality performance, MIPS
Troy Beaucoudray, M.D.'s 2023 MIPS final score plotted against the Pain Medicine (Psychiatry & Neurology) Physician national average
- MIPS Final Score
- 17.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1316105182 |
|---|---|
| Specialty | Pain Medicine (Psychiatry & Neurology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/29/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
17.5
Final Score
Measured-score avg: 83.5
25
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Troy Beaucoudray, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.1K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Troy Beaucoudray, M.D. - brand share 7.0%
Pain Medicine (Psychiatry & Neurology) Physician average
7% brand-name claims vs 93% generic, on 13,605 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
13,605
Total Claims
$1.2M
Total Drug Cost
626
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 14,659.667
- Total Day Supply
- 431,630
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $799K
- Generic Drug Cost
- $362K
- Opioid Claims
- 6,811 (50.1% rate)
Patient Demographics
- Average Patient Age
- 63.2 years
- Avg HCC Risk Score
- 1.42
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 296, 65-74: 261, 75-84: 58, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Troy Beaucoudray, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
2,466 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
1,519 claims
- Oxycodone Hcl
Oxycodone Hcl
1,165 claims
- Tizanidine Hcl 979
Tizanidine Hcl
979 claims
- Gabapentin 878
Gabapentin
878 claims
- Morphine Sulfate Er 660
Morphine Sulfate Er
660 claims
- Ibuprofen 601
Ibuprofen
601 claims
- Cyclobenzaprine Hcl 377
Cyclobenzaprine Hcl
377 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,466 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,519 |
| Oxycodone Hcl | 1,165 |
| Tizanidine Hcl | 979 |
| Gabapentin | 878 |
| Morphine Sulfate Er Morphine Sulfate | 660 |
| Ibuprofen | 601 |
| Cyclobenzaprine Hcl | 377 |
| Methocarbamol | 339 |
| Baclofen | 315 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Pain Medicine (Psychiatry & Neurology) Physician in LA →
All providers in Louisiana →
Compare specialties →
Pain Medicine (Psychiatry & Neurology) Physician Overview
How Troy Beaucoudray, M.D. fits within the Pain Medicine (Psychiatry & Neurology) Physician landscape nationally.
169
Pain Medicine (Psychiatry & Neurology) Physician Providers in US
40
States with Pain Medicine (Psychiatry & Neurology) Physician
1,672
Avg Claims per Provider
Troy Beaucoudray, M.D.'s 13,605 claims are above the specialty average of 1,672.
Nationwide Pain Medicine (Psychiatry & Neurology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Beaucoudray, both outside Louisiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (17.5 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pain Medicine (Psychiatry & Neurology) Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Beaucoudray.
One of 3 Pain Medicine (Psychiatry & Neurology) Physician providers enrolled in Louisiana, 2 are shown here.
Frequently Asked Questions
What is Troy Beaucoudray, M.D.'s specialty? ▼
Troy Beaucoudray, M.D. specializes in Pain Medicine (Psychiatry & Neurology) Physician and practices in Metairie, Louisiana. Credentials: M.D..
How much does Troy Beaucoudray, M.D. prescribe under Medicare Part D? ▼
In 2024, Troy Beaucoudray, M.D. wrote 13,605 Medicare Part D claims totaling $1.2M in drug costs for 626 beneficiaries.
What is Troy Beaucoudray, M.D.'s Medicare quality score? ▼
Troy Beaucoudray, M.D. has a CMS MIPS Final Score of 17.5/100 (Quality: 25). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Troy Beaucoudray, M.D. located? ▼
Troy Beaucoudray, M.D. is located at 3409 DIVISION ST, Metairie, LA, 70002. Phone: (504) 454-7246.
What is Troy Beaucoudray, M.D.'s NPI number? ▼
Troy Beaucoudray, M.D.'s National Provider Identifier (NPI) is 1316105182, issued on 05/29/2008.
Does Troy Beaucoudray, M.D. prescribe more brand-name or generic drugs? ▼
Troy Beaucoudray, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $799K in brand drug costs.
Does Troy Beaucoudray, M.D. prescribe opioids? ▼
Yes, Troy Beaucoudray, M.D. had 6,811 opioid claims in 2024 with an opioid prescribing rate of 50.1%.
How many Pain Medicine (Psychiatry & Neurology) Physician providers are there in the US? ▼
There are 169 Pain Medicine (Psychiatry & Neurology) Physician providers across 40 states in the US. The average Pain Medicine (Psychiatry & Neurology) Physician provider writes 1,672 Medicare Part D claims per year.
What drugs does Troy Beaucoudray, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Troy Beaucoudray, M.D.'s most frequently prescribed drugs include Hydrocodone-Acetaminophen, Oxycodone-Acetaminophen, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Troy Beaucoudray, M.D. accept Medicare? ▼
Troy Beaucoudray, M.D. appears in CMS Medicare data with 13,605 Part D claims and 626 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Troy Beaucoudray, M.D.'s credentials? ▼
Troy Beaucoudray, M.D.'s NPI is 1316105182 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.